TLSA Tiziana Life Sciences Ltd

0.67
0.0101 (1.53%)
Last Updated: 13:18:24
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Period:

Draw Mode:

Volume 33,885
Bid Price 0.66
Ask Price 0.675
News -
Company Name Stock Ticker Symbol Market Type
Tiziana Life Sciences Ltd TLSA NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.0101 1.53% 0.67 13:18:24
Open Price Low Price High Price Close Price Prev Close
0.64 0.6302 0.68 0.6599
Trades Volume VWAP Dollar Volume Avg Volume
101 33,885  0.6669294  22,599 -
Last Trade Time Type Quantity Stock Price Currency
13:16:20 1,200  0.67 USD

Tiziana Life Sciences Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 68.52M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Tiziana Life Sciences

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TLSA Message Board. Create One! See More Posts on TLSA Message Board See More Message Board Posts

TLSA Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn's Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products.
Your Recent History
NASDAQ
TLSA
Tiziana Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now